These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 31983106)

  • 21. Single agent weekly paclitaxel as neoadjuvant chemotherapy in locally advanced breast cancer: a feasibility study.
    Gupta S; Bharath R; Shet T; Desai SB; Patil VM; Bakshi A; Parmar V; Badwe RA
    Clin Oncol (R Coll Radiol); 2012 Nov; 24(9):604-9. PubMed ID: 22014455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Weekly one-hour paclitaxel as first-line chemotherapy for metastatic breast cancer.
    Wist EA; Sommer HH; Ostenstad B; Risberg T; Fjaestad K
    Acta Oncol; 2004; 43(1):11-4. PubMed ID: 15068314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efficacy of supportive care for albumin-bound paclitaxel(nab-paclitaxel)in 20 patients with metastatic breast cancer].
    Yamada C; Yonezawa M; Shimizu Y; Taga R; Kashihara H; Tsuji K; Murata T; Yoshino H
    Gan To Kagaku Ryoho; 2014 Jan; 41(1):77-81. PubMed ID: 24423956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolonged administration of weekly paclitaxel and trastuzumab in patients with advanced breast cancer.
    Christodoulou C; Klouvas G; Pateli A; Mellou S; Sgouros J; Skarlos DV
    Anticancer Res; 2003; 23(1B):737-44. PubMed ID: 12680177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II study of weekly paclitaxel for advanced or metastatic breast cancer in Japan.
    Horiguchi J; Rai Y; Tamura K; Taki T; Hisamatsu K; Ito Y; Seriu T; Tajima T
    Anticancer Res; 2009 Feb; 29(2):625-30. PubMed ID: 19331212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Weekly paclitaxel in women age 65 and above with metastatic breast cancer.
    Perez EA; Vogel CL; Irwin DH; Kirshner JJ; Patel R
    Breast Cancer Res Treat; 2002 May; 73(1):85-8. PubMed ID: 12083634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paclitaxel-induced acral erythema.
    Richards KN; Ivan D; Rashid RM; Chon SY
    Arch Dermatol; 2012 Nov; 148(11):1333-4. PubMed ID: 23165853
    [No Abstract]   [Full Text] [Related]  

  • 28. Weekly paclitaxel in pretreated metastatic breast cancer: retrospective analysis of 52 patients.
    Baltali E; Altundag K; Ozisik Y; Guler N; Tekuzman G
    Tohoku J Exp Med; 2004 Jul; 203(3):205-10. PubMed ID: 15240930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Taxanes versus S-1 as the first-line chemotherapy for metastatic breast cancer (SELECT BC): an open-label, non-inferiority, randomised phase 3 trial.
    Takashima T; Mukai H; Hara F; Matsubara N; Saito T; Takano T; Park Y; Toyama T; Hozumi Y; Tsurutani J; Imoto S; Watanabe T; Sagara Y; Nishimura R; Shimozuma K; Ohashi Y;
    Lancet Oncol; 2016 Jan; 17(1):90-8. PubMed ID: 26617202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case report: paclitaxel-induced myocardial ischemia.
    Soe MS; Berkman A; Mardelli TJ
    Md Med J; 1996 Jan; 45(1):41-3. PubMed ID: 8569460
    [No Abstract]   [Full Text] [Related]  

  • 31. Single-agent docetaxel in metastatic breast cancer patients pre-treated with anthracyclines and paclitaxel: partial cross-resistance between paclitaxel and docetaxel.
    Lin YC; Chang HK; Wang CH; Chen JS; Liaw CC
    Anticancer Drugs; 2000 Sep; 11(8):617-21. PubMed ID: 11081452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: preliminary data of a prospective randomized trial.
    Buzdar AU; Singletary SE; Valero V; Booser DJ; Ibrahim NK; Rahman Z; Theriault RL; Walters R; Rivera E; Smith TL; Holmes FA; Hoy E; Frye DK; Manuel N; Kau SW; McNeese MD; Strom E; Thomas E; Hunt K; Ames F; Berry D; Hortobagyi GN
    Clin Cancer Res; 2002 May; 8(5):1073-9. PubMed ID: 12006521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of cystic maculopathy during paclitaxel therapy].
    Ito S; Okuda M
    Nippon Ganka Gakkai Zasshi; 2010 Jan; 114(1):23-7. PubMed ID: 20112801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical experience of nab-Paclitaxel treatment in 31 patients with breast cancer].
    Tauchi Y; Kashiwagi S; Ishihara S; Asano Y; Sakimura C; Kurata K; Tokumoto M; Morisaki T; Noda S; Kawajiri H; Takashima T; Onoda N; Hirakawa K
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1948-50. PubMed ID: 25731385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phase II trial of paclitaxel (Taxol) as first line treatment in advanced breast cancer.
    Swain SM; Honig SF; Tefft MC; Walton L
    Invest New Drugs; 1995; 13(3):217-22. PubMed ID: 8729949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TP53 mutation and p53 overexpression for prediction of response to neoadjuvant treatment in breast cancer patients.
    Kandioler-Eckersberger D; Ludwig C; Rudas M; Kappel S; Janschek E; Wenzel C; Schlagbauer-Wadl H; Mittlböck M; Gnant M; Steger G; Jakesz R
    Clin Cancer Res; 2000 Jan; 6(1):50-6. PubMed ID: 10656431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histopathological improvement of scleroderma induced by paclitaxel in a patient with breast cancer.
    Ohashi A; Minagawa A; Ashida A; Koga H; Uhara H; Okuyama R
    J Dermatol; 2015 Dec; 42(12):1198-9. PubMed ID: 26333146
    [No Abstract]   [Full Text] [Related]  

  • 38. A detailed evaluation of cardiac toxicity: a phase II study of doxorubicin and one- or three-hour-infusion paclitaxel in patients with metastatic breast cancer.
    Giordano SH; Booser DJ; Murray JL; Ibrahim NK; Rahman ZU; Valero V; Theriault RL; Rosales MF; Rivera E; Frye D; Ewer M; Ordonez NG; Buzdar AU; Hortobagyi GN
    Clin Cancer Res; 2002 Nov; 8(11):3360-8. PubMed ID: 12429622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neoadjuvant chemotherapy with weekly paclitaxel in breast cancer patients may increase release of cancer cells into circulation by decreasing interstitial fluid pressure.
    Altundag O; Altundag K; Gundeslioglu O; Silay YS; Ersoy Y
    Med Hypotheses; 2006; 66(4):857-8. PubMed ID: 16039067
    [No Abstract]   [Full Text] [Related]  

  • 40. [Administration of nab-paclitaxel for 9 metastatic breast cancer patients].
    Sakaguchi K; Mizuta N; Imai A; Nakatsukasa K; Morita M; Soushi M; Taguchi T
    Gan To Kagaku Ryoho; 2012 Jul; 39(7):1081-5. PubMed ID: 22790043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.